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Keratin 9 Is Required for the Structural Integrity and
Terminal Differentiation of the Palmoplantar Epidermis
Dun Jack Fu1, Calum Thomson2, Declan P. Lunny3, Patricia J. Dopping-Hepenstal4, John A. McGrath5,
Frances J.D. Smith1, W.H. Irwin McLean1 and Deena M. Leslie Pedrioli1
Keratin 9 (K9) is a type I intermediate filament protein whose expression is confined to the suprabasal layers of
the palmoplantar epidermis. Although mutations in the K9 gene are known to cause epidermolytic palmoplantar
keratoderma, a rare dominant-negative skin disorder, its functional significance is poorly understood. To gain
insight into the physical requirement and importance of K9, we generated K9-deficient (Krt9 / ) mice. Here, we
report that adult Krt9 /mice develop calluses marked by hyperpigmentation that are exclusively localized to the
stress-bearing footpads. Histological, immunohistochemical, and immunoblot analyses of these regions revealed
hyperproliferation, impaired terminal differentiation, and abnormal expression of keratins K5, K14, and K2.
Furthermore, the absence of K9 induces the stress-activated keratins K6 and K16. Importantly, mice heterozygous
for the K9-null allele (Krt9þ / ) show neither an overt nor histological phenotype, demonstrating that one Krt9
allele is sufficient for the developing normal palmoplantar epidermis. Together, our data demonstrate that
complete ablation of K9 is not tolerable in vivo and that K9 is required for terminal differentiation and
maintaining the mechanical integrity of palmoplantar epidermis.
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INTRODUCTION
Keratin 9 (K9; gene name KRT9 in humans; Krt9 in mice), is a
type I intermediate filament protein specifically expressed in
the suprabasal layers of the primary epidermal ridges of the
palmoplantar epidermis in humans (Knapp et al., 1986;
Swensson et al., 1998). In adult mice, Krt9 is expressed
in the footpads, which is equivalent to human thick
skin (Schweizer et al., 1989). In both humans and mice,
the palmoplantar epidermis must withstand the highest
degree of mechanical stress the body is exposed to and is,
therefore, a highly specialized tissue abundantly expressing a
diverse set of keratins. The site and tissue-specific expression
pattern of Krt9 in glabrous epidermis has been postulated
to provide additional mechanical reinforcement by pro-
moting filament bundling (Schweizer et al., 1989; Swensson
et al., 1998). Nevertheless, the functional importance
and specific requirement for K9, as well as other indivi-
dual keratins, within the palmoplantar epidermis remains
unclear.
Epidermolytic palmoplantar keratoderma (EPPK) is one of
430 rare autosomal-dominant human keratinizing disorders
characterized by diffuse hyperkeratosis on the palms and soles
(Omary et al., 2004; McLean and Irvine, 2007; McLean and
Moore, 2011; Haines and Lane, 2012). EPPK is unique among
the keratinopathies, in that it is exclusively caused by
dominant-negative mutations in KRT9 (Smith, 2003; McLean
and Irvine, 2007). This pathomechanism makes EPPK well
suited for the development of RNA interference-based
therapeutics that specifically inhibits the activity of the
causative keratin allele. The monogenic nature of EPPK; the
hotspot mutations in KRT9 that account for the majority of all
EPPK cases; the well-circumscribed and accessible treatment
area; and the abundance of other keratins in the palmoplantar
epidermis, all combine to make this a good model disease
for therapeutic small interfering RNA (siRNA) proof-of-
concept studies. To this end, we recently developed a
RNA interference-based therapeutic package for EPPK with
mutation-specific siRNAs that inhibit four of the most common
KRT9 mutations (Leslie Pedrioli et al., 2012). No recessive or
loss-of-function mutations have been reported for KRT9 and
functional redundancy has been shown for other palmoplantar
keratins (Porter and Lane, 2003; Coulombe et al., 2004; Lu
et al., 2006). It, therefore, also stands to reason that complete
inhibition of KRT9 might be a viable therapy strategy for EPPK.
To investigate this, potent generic siRNAs that target KRT9
regardless of the EPPK mutation status were also developed
(Leslie Pedrioli et al., 2012).
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Although our proof-of-principle studies demonstrated
specificity and potency of K9 siRNAs both in vitro and
in vivo, we were unable to assess their efficacy, tolerance,
or potential therapeutic benefits under endogenous conditions
(Leslie Pedrioli et al., 2012). Furthermore, a recent study
demonstrating that K16-null mice develop a phenotype
closely resembling palmoplantar keratoderma (Lessard and
Coulombe, 2012) strongly suggested that keratin functional
redundancy within the palmoplantar epidermis may not be as
extensive as originally thought. To determine whether com-
plete ablation of K9 in vivo could be a viable therapeutic
option for EPPK patients and define the functional importance
of this palmoplantar keratin in vivo, we generated gene-
targeted mice deficient for Krt9.
RESULTS
K9-deficient (Krt9 / ) mice develop hyperpigmented calluses
on their stress-bearing footpads
Krt9-null mice were generated using Krt9-null C57 Bl/6NTac
ES cells obtained from the Knock-Out Mouse Project reposi-
tory (Supplementary Figure S1a online; see Supplementary
Information online). Krt9þ /þ , Krt9þ / , and Krt9 / mice
were born at approximate Mendelian ratios. Appropriate
expression of Krt9 and lacZ within the suprabasal layers of
palmoplantar epidermis (Knapp et al., 1986; Schweizer et al.,
1989; Swensson et al., 1998) of Krt9þ /þ , Krt9þ / , and
Krt9 / littermates was confirmed via western blotting and
immunohistochemical staining (Supplementary Figure S1b
and S1c online; see Supplementary Information online).
Initially, newborn Krt9þ / and Krt9 / mice were visually
indistinguishable from Krt9þ /þ littermates. Surprisingly,
hyperpigmented calluses began to develop on the rear,
stress-bearing fore-paw footpads of Krt9 / animals between
3 and 4 weeks of age, which persisted into adulthood
(Figure 1a). We monitored the progression of this phenotype
at weekly intervals in adult mice and found that the presence,
severity and pigmentation state of these calluses cycled over
the 8-week study period (Figure 1b). Indeed, every 3 weeks we
observed hyperpigmentation intensify and callus size increase
and then, just prior to the callus sloughing-off, localized
flakiness would develop on the calluses. This phenotype was
most evident on the major footpads of the fore-paws, but it
was also observed to a lesser extent on the minor footpads of
both the fore- and hind-paws of these animals (Figure 1b; and
data not shown). Importantly, neither the presence nor state of
the callus appeared to affect animal mobility or their ability to
thrive. This phenotype was not observed in Krt9þ /þ and
Krt9þ / littermates (Figure 1a; and data not shown).
K9-null mouse fore- and hind-paw footpads develop localized
acanthosis and hyperkeratosis
Histological analysis of the fore- and hind-paw footpads of 8-
week old Krt9þ /þ , Krt9þ / , and Krt9 / littermates revealed
acanthosis, hyperkeratosis, and occasional hypergranulosis
within the footpads of Krt9-null mice (Figure 2a and
Supplementary Figure S2 online). Compared to Krt9þ /þ and
Krt9þ / littermates, the epidermis of Krt9 / footpad
regions was thicker and papillomatous. Within the stratum
granulosum of these mice, impaired keratinocyte flattening
was observed, which coincided with the presence of larger,
abnormally shaped, and nucleated keratinocytes (Figure 2a
and Supplementary Figure S2 online). Importantly, these
hyperkeratotic features were not present in the inter-footpad
plantar epidermis of any of the animals studied (Figure 2b; and
data not shown). Finally, Fontana–Masson staining revealed
that melanin staining was specific to Krt9 / fore-paw footpad
sections (Supplementary Figure S3 online), indicating an
increased presence of melanosomes.
In an attempt to quantify the differences in footpad and
inter-footpad epidermal thickness between the Krt9 genotypes,
10 independent measurements of these fore-paw tissues were
taken and the average thickness across the footpad and inter-
footpad regions calculated. When comparing the three geno-
types, negligible differences were observed in the thickness of
the inter-footpad regions. In contrast, although similar footpad
thickness was recorded for Krt9þ /þ and Krt9þ / tissues,
Krt9 / footpads wereB3 times thicker than their littermates
(Figure 2b). The same trend was observed in a separate
analysis of the hind-paws (data not shown), but the hyperker-
atosis and acanthosis observed here were generally less severe
than in the fore-paws (Supplementary Figure S2 online).
Ultrastructural analysis of keratotic phenotypes in Krt9 / mice
Low magnification scanning electron microscopy was used to
further examine the major fore-paw footpads of 8-week old
Krt9þ /þ , Krt9þ / , and Krt9 / littermates (Supplementary
Figure S4 online). The major footpads of Krt9þ /þand Krt9þ /
mice were similar in size and were smooth. In contrast, Krt9 /
footpads were larger and had an uneven, rough surface with
significant fissures (Supplementary Figure S4 online). These
surface features were reminiscent of the epidermal thickening
and fissuring observed in various human keratodermas caused
by keratin gene mutations (Morais et al., 2009). Transmission
electron microscopy ultrastructural analysis comparing the
footpad epidermis of Krt9þ /þ to Krt9 / was carried out.
This confirmed that loss of K9 results in acanthotic and
hyperkeratotic fore-paw footpads, and revealed cytolysis-
associated splits through the spinous layer (Figure 3a and
Supplementary Figure S5 online). In addition, widespread
pallor and a general lack of keratin intermediate filaments
was observed in Krt9 / spinous layer keratinocytes
(Figure 3b). These findings suggest that the spinous layer
may be the site of maximal weakness in Krt9 / fore-paw
footpads. Interestingly, despite a reduction in keratin filaments,
no morphological differences were observed between the
desmosomes of Krt9þ /þ and Krt9 / mice (Figure 3c). This
is consistent with observations made in Krt5-null, Krt6a/b-null,
Krt14-null, and Krt18-null mice (Lloyd et al., 1995; Magin
et al., 1998; Wong et al., 2000; Peters et al., 2001), as well as
patients with KRT14-null mutations (Jonkman et al., 1996;
Chan et al., 2000).
Proliferation and differentiation are disrupted in the
absence of K9
The acanthotic and hyperkeratotic phenotypes observed in the
Krt9 / footpads prompted us to examine whether the
DJ Fu et al.
K9 Is an Essential Palmoplantar Keratin
www.jidonline.org 755
expression and/or localization of proliferation and terminal
differentiation markers were altered in response to loss of K9.
Immunoperoxidase staining for the proliferation marker Ki-67
and the transcription factor p63, a key regulator of basal
keratinocyte proliferation, differentiation, and survival (Candi
et al., 2008), revealed an increase in the number and staining
intensity of Ki-67- and p63-positive cells, respectively, in the
footpads of Krt9 / mice (Figure 4). Quantification of the
number of Ki-67-positive basal keratinocytes revealed an
increase in these cells in Krt9 / tissues (83%) compared
with Krt9þ /þ (60%) and Krt9þ / (58%) footpads (data not
shown).
These findings and our observation that Krt9 / granular
keratinocytes failed to compact into a well-ordered granular
layer, prompted us to investigate whether loss of K9 affected
keratinocyte differentiation. This was achieved by examining
Krt9+/+ Krt9 +/– Krt9 –/–
Week 1 Week 2 Week 3 Week 4
Week 5 Week 6 Week 7 Week 8
Figure 1. The stress-bearing footpads of fore-paws in keratin 9-deficient (Krt9 / ) mice develop hyperpigmented calluses. The fore- and hind-paws of 8-week
old Krt9þ /þ , Krt9þ / , and Krt9 / littermates (n¼ 4 per genotype) were photographed weekly over an 8-week period. (a) Initial observation in week 1 revealed
hyperpigmented calluses on the major stress-bearing fore-paw footpads of adult Krt9 / mice (arrows). (b) In Krt9 / mice, callus size and hyperpigmentation
state grew and intensified, respectively, over a B3-week period on the major footpads before sloughing off (arrows). Similar, but milder, calluses were also
observed on the minor fore-paw footpads of Krt9 / mice, which also appeared to cycle but at a slower rate (arrowhead).
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the epidermal localization profiles of the stratum granulosum
markers, loricrin and filaggrin (Candi et al., 2005), in Krt9þ /þ ,
Krt9þ / , and Krt9 / littermates (Figure 4). Although both
loricrin and filaggrin localized appropriately to the stratum
granulosum of Krt9 / fore-paw footpads, a significant
increase in loricrin staining intensity and retention within the
stratum corneum was observed. In addition, compared with
Krt9þ /þ and Krt9þ / sections, intermittent and disorganized
filaggrin staining was observed in Krt9 / footpads. Collec-
tively, these findings suggest that the localized acanthosis and
hyperkeratosis phenotypes may be triggered by an increase in
the proliferation state of basal keratinocytes and more rapid
transition towards terminal differentiation, which ultimately
impairs terminal differentiation and cornification.
Loss of K9 alters the expression patterns of a subset of
palmoplantar keratins
Immunoperoxidase staining and western blotting were used to
determine whether K9 ablation affected the levels and locali-
zation patterns of the other keratins expressed in the footpad
(Schweizer et al., 1989; Swensson et al., 1998). Importantly,
due to the localized expression of K9 in the footpads and the
footpad-restricted hyperkeratosis in K9-null mice we analyzed
these regions separately from the inter-footpad tissues
(Figure 5 and Supplementary Figure S6 online).
While the basal layer keratins, K5 and K14, were
appropriately localized to the basal layer in Krt9þ /þ and
Krt9þ / footpads, their localization patterns extended into
the suprabasal epidermis, and as far up as the uppermost
granular layer, in some regions in Krt9 / footpad tissues
(Figure 5a). Semiquantitative western blotting for K14 demon-
strated that the spatial localization changes did not affect its
overall abundance (Figure 5b). Surprisingly, compared with
Krt9þ /þ tissues, we noted a 53% decrease in K5 protein levels
only in Krt9 / footpads (Figure 5b and c, and
Supplementary Figure S6 online). The levels and distribution
of the suprabasal keratins, K1 and K10, did not change
significantly in response to loss of K9 in neither the footpad
(Figure 5a and b), nor the inter-footpad regions (Supple-
mentary Figure S6 online). Finally, K2 staining revealed that
Krt9+/+ Krt9 +/– Krt9 –/–
Krt9+/+ Krt9 +/– Krt9 –/–
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Figure 2. Localized keratotic phenotypes develop in adult keratin 9-deficient (Krt9 / ) footpads. (a) Hematoxylin and eosin-stained cross-sections of formalin
fixed, paraffin-embedded major fore-paw footpads of Krt9þ /þ , Krt9þ / , and Krt9 / littermates (n¼ 3 per genotype) revealed acanthosis, hyperkeratosis, and
sporadic hypergranulosis in Krt9 / mice. Granular keratinocytes also failed to compact in these animals and dark pigment granules (circled) were
observed in all strata. Scale bar¼100mm. (b) Axiovision imaging software was used to measure the thickness of the footpad and inter-footpad epidermis in
hematoxylin and eosin-stained fore-paw cross-sections from Krt9þ /þ , Krt9þ / , and Krt9 / animals. Graph depicts the mean thickness of each region calculated
from 10 independent measurements taken over the length of a representative section from each genotype (n¼3) and the error bars represent SD. ***Pp0.0001.
DJ Fu et al.
K9 Is an Essential Palmoplantar Keratin
www.jidonline.org 757
this keratin is specifically expressed at the borders of the
glabrous footpad and within the inter-footpad regions of the
plantar epidermis (Figure 5a and data not shown). In addition,
semiquantitative western blotting demonstrated that the levels
of K2 decreased by 60% in the fore-paw footpads in Krt9 /
animals compared with Krt9þ /þand Krt9þ / mice (Figure 5b
and c). Similar reductions in K2 protein levels were also noted
in Krt9 / inter-footpad tissues (Supplementary Figure S6
online).
In addition to the palmoplantar keratins, we also deter-
mined how K9 ablation affected the expression of the stress-
response and wound-healing keratins, K6 and K16
Krt9 +/+
Krt9 +/+ Krt9 –/–
Krt9 –/–
Figure 3. Ultrastructural analysis of keratin 9-deficient (Krt9 / ) fore-paw footpads shows disrupted cytoskeletal integrity and keratin filament assembly.
(a) Krt9 / keratinocytes adjacent to the area of blistering (asterisk) show cytoplasmic disruption with evident cytolysis (green arrow), fewer keratin filaments and
some filament, or keratin protein aggregation (blue arrow). Scale bar¼ 1 mm. (b) Compared with Krt9þ /þ , loss of K9 in leads to relative pallor in Krt9 /
keratinocyte cytoplasm. Scale bar¼0.2mm. (c) Despite loss of K9 (right panel), desmosome cell–cell junctions are similar in size and morphology to Krt9þ /þ
desmosomes (left panel). Interestingly, fewer keratin filaments are seen in the adjacent cytoplasm in Krt9 / fore-paw tissues. Both Krt9þ /þ and Krt9 /
desmosomes shown here are within the mid-spinous layer. Scale bar¼0.1mm.
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(Leigh et al., 1995). Immunoperoxidase staining for K6 in
Krt9þ /þ , Krt9þ / , and Krt9 / littermates revealed that Krt6
expression was specifically and exclusively induced in the
suprabasal layers of Krt9 / glabrous footpad tissues
(Figure 5a). Moreover, K6 and K16 were only detectable by
western blotting in Krt9 / footpad lysates (Figure 5b).
Quantification of Krt9 / signals, relative to Krt9þ /þ and
Krt9þ / signals, revealedB15- andB11-fold increases in K6
and K16 respective band intensities (Figure 5d). Surprisingly,
increased K16 levels were also detected in Krt9 / inter-
footpad tissues despite the absence of hyperkeratosis in these
areas (Supplementary Figure S6 online).
DISCUSSION
K9-null mice developed hyperpigmented calluses on the
major stress-bearing footpads of the fore-paws, which were
also sporadically visible on minor footpads of both the fore-
and hind-paws. Histologically, these lesions showed promi-
nent hyperkeratosis and acanthosis, which resulted in signifi-
cant footpad epidermal thickening. Importantly, this well-
circumscribed phenotype coincides with the footpad-restricted
Krt9 expression pattern observed here and reported previously
(Schweizer et al., 1989). These findings demonstrate that K9 is
required for normal palmoplantar physiology, that its loss
cannot be tolerated in vivo and begin to explain why K9 is
evolutionarily conserved in mammals. Moreover, our data
imply that K9 provides the critical mechanical reinforcement
required for these weight-bearing tissues to withstand the
continual load-bearing impact. This is supported by our
observation that the most severe forms of the K9-null kera-
toderma phenotype develop on the major impact-dampening
footpads of the main weight-bearing paws, the fore-paw, of
the mice.
Melanin staining suggests that the hyperpigmentation phe-
notype, which accompanies Krt9 / footpad hyperkeratosis
and acanthosis, results, at least in part, from a marked increase
in the number of melanosomes present in Krt9 / fore-paw
footpad tissues. As increased melanocyte infiltration at the
dermal–epidermal interface and/or melanocyte proliferation
could also contribute to this phenotype (Yamaguchi et al.,
2007), additional experiments are required to fully define the
molecular cause of Krt9 / fore-paw footpad hyperpigmen-
tation. Moreover, ultrastructural analyses of the localized
phenotype showed cytolysis-associated suprabasal splits with
a significant reduction of keratin filaments. Compared with
wild-type samples, alterations in the number and morphology
of desmosomes in these regions were not observed in K9-null
footpad tissues. Nevertheless, as fewer intermediate filaments
are present in Krt9 / tissues, additional studies defining the
molecular composition and functional integrity of these
Krt9 / desmosomes are required. These studies will allow
us to pin-point the molecular source of Krt9 / footpad
weakness and determine whether compromised desmosome
function contributes to phenotype development.
The EPPK-like phenotype observed here was less severe
than that recently reported in K16-null animals (Lessard and
Coulombe, 2012). Krt16 / mice develop an explicit
palmoplantar keratoderma, similar to that seen in the human
K16 subtype of pachyonychia congenita 16 (McLean et al.,
1995; McLean and Moore, 2011), which compromised animal
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Figure 4. Hyperproliferation in adult keratin 9-deficient (Krt9 / ) footpad epidermis. Immunoperoxidase staining of formalin fixed, paraffin-embedded
fore-paw footpads from Krt9þ /þ , Krt9þ / , and Krt9 / littermates (n¼ 3 per genotype) with a-Ki-67 (Ki67; MM1-L-CE), a-p63 (p63; SC8431), a-loricrin
(LOR; AF62), and a-filaggrin (FLG; gift from Richard Presland, Seattle, WA) antibodies. Note the overall increase in Ki-67-positive basal layer keratinocytes, as well
as increased Ki-67 and p63 staining intensities, in the Krt9 / cross-sections relative to Krt9þ /þ and Krt9þ / samples. Although both FLG and LOR localized to
the stratum granulosum in all genotypes, LOR staining in Krt9 / cross-sections was stronger and extended into the stratum corneum. In addition, FLG appeared
patchy and disorganized in Krt9 / samples. Scale bar¼50mm.
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Figure 5. Keratin 9-deficient (Krt9 / )-knockout alters the expression patterns of a subset of palmoplantar keratins. (a) Immunoperoxidase staining of
fore-paw footpads from Krt9þ /þ , Krt9þ / , and Krt9 / littermates (n¼ 3 per genotype) with a-K5, a-K14, a-K1, a-K10, a-K2, and a-K6. Note increased
suprabasal staining of K5 and K14, and increased K6 staining in Krt9 / cross-sections. Scale bar¼50mm. (b) Immunoblotting of fore-paw footpad whole-tissue
lysates Krt9þ /þ , Krt9þ / , and Krt9 / littermates (n¼3 per genotype) with a-K5, a-K14, a-K1, a-K10, a-K2, a-K6, a-K16, and a-b-actin (loading control;
representative image shown) antibodies and differential fluorescence visualization. (c, d) Semiquantitative immunoblotting analyses of a-K5, a-K2, a-K6, and
a-K16, relative to b-actin, were used to quantify protein abundance changes following loss of K9. Mean relative abundances (n¼ 3) are shown, and error bars
indicate signal intensity SD. *Pp0.05; **Pp0.01.
DJ Fu et al.
K9 Is an Essential Palmoplantar Keratin
760 Journal of Investigative Dermatology (2014), Volume 134
mobility and appeared painful. When comparing EPPK and
pachyonychia congenita 16 with the recessive K9-null and
K16-null palmoplantar keratodermas, respectively, it is inter-
esting how closely the human and rodent disease severities
and functional consequences mimic one another. Indeed,
similar to what was observed in the K9-null and K16-null
animals, the clinical features of EPPK are much milder and do
not appear to affect the patient’s quality of life as significantly
as pachyonychia congenita 16, which can be extremely
painful and severely debilitating for patients (McLean and
Moore, 2011; Haines and Lane, 2012).
Further examination of the K9-null phenotype revealed an
induction in the expression of the stress-activated keratins K6
and K16 (Leigh et al., 1995) within the major footpads of the
fore-paws. Surprisingly, we also found increased levels of K16
in seemingly unaffected inter-footpad epidermis where K9 is
normally not expressed, suggesting that a trauma-induced
paracrine signaling mechanism controls Krt16 expression.
Why K6 was not also induced here is unclear, but this may
indicate that the K16 gene is more sensitive to this unknown
paracrine effect. Perhaps nominal inter-footpad stress caused
by K9-null footpad mechanical weakness triggers a sufficient
response to induce K16, but not K6. Moreover, intensified
footpad Ki-67 and p63 staining suggests that regional
stress/weakness stimulates keratinocyte proliferation, which
ultimately results in epidermal thickening. This process is
somewhat analogous to what is observed in human dominant-
negative keratin disorders, including EPPK, epidermolytic
ichthyosis, or superficial epidermolytic ichthyosis (previously
known as ichthyosis bullosa of Siemens; Oji et al., 2010;
McLean and Moore, 2011; Haines and Lane, 2012), where
suprabasal mechanical fragility leads to overgrowth of the
affected tissue. Terminal differentiation was also clearly
disrupted in the footpad epidermis of K9-null mice. Changes
in key epidermal barrier proteins, such as loricrin and
filaggrin, were also noted. The highly abnormal, grossly
thickened stratum corneum in Krt9 / animals suggests that
additional changes in corneocyte integrity, skin barrier
proteins and lipid components may occur secondary to loss
of K9.
In addition to the very apparent upregulation of stress-
related keratins, a number of more subtle secondary effects on
other keratins were observed in the footpads of K9-null mice.
Due to the high degree of sequence homology shared by
K10 and K9, and their overlapping suprabasal palmoplantar
expression patterns (Reichelt et al., 2001), it has long
been postulated that K9 may also interact with K1 in the
palmoplantar epidermis. If true, one might expect a similar
decrease in K1 protein levels in the footpads of K9-null mice
as observed following K10 ablation (Reichelt and Magin,
2002). As no change in the quantity or distribution of K1
was observed in Krt9 / footpads, K9 may not interact with
K1 here. Surprisingly, K5 protein levels decreased in Krt9 /
tissues suggesting that K5 may be the type II keratin-binding
partner of K9 in the palmoplantar/footpad epidermis. Overall,
the reduction in keratin protein levels was very subtle given
the striking reduction in visible intermediate filaments by
electron microscopy. This, and the presence of keratin
protein aggregates in Krt9 / spinous layer keratinocytes,
suggests that the pool of soluble keratins increases in these
tissues; presumably due to impaired keratin polymerization.
Further work is required to fully define the direct and
indirect interactions and assembly preferences for the complex
mixture of keratins found in footpad/palmoplantar epidermis.
In the future, it will also be important to catalogue and
understand how loss of a suprabasal keratin affects the stratum
corneum and impedes terminal differentiation. Such experi-
ments are essential when considering the potential implica-
tions therapeutic manipulation will have on keratin
expression. Moreover, although the primary genetic basis of
several keratin disorders is well understood, the secondary
molecular mechanisms and signaling pathways involved in
producing hyperkeratosis, regardless of the genetically deter-
mined mechanical insult (dominant mutation or ablation of
various keratins), remain poorly understood. The availability
of K9-null mice, which develop a form of hyperkeratosis
similar to that seen in human keratinizing disorders, will
facilitate future systems biology studies aimed at identifying
candidate pathways and signaling molecules involved in this
process. Indeed, identification of such common pathways, if
they exist, could seed the development of a generic treatment
for hyperkeratotic skin conditions.
It is clear that K9 is not completely dispensable in mice,
therefore it is unlikely that siRNAs aimed at complete KRT9
deletion in EPPK patients will be a therapeutically viable
option. Importantly, this study has demonstrated that the
palmoplantar epidermis develops normally in heterozygous
K9-null mice and established that a single copy of Krt9 is
sufficient to maintain healthy skin in vivo. These results are of
great significance as they indicate that the mutation-specific
siRNA we recently developed for treating EPPK (Leslie Pedrioli
et al., 2012) are clinically viable and may, indeed, prove to be
therapeutically beneficial for patients.
In conclusion, we have shown that K9 is required for mouse
footpad epidermis mechanical integrity and correct terminal
differentiation and, by implication, in the palmoplantar epi-
dermis in humans. In addition to providing supportive data to
justify our pursuit of mutation-specific RNA interference-based
treatments for EPPK, this new mouse model is a valuable asset
for future studies aimed at understanding the process of
hyperkeratosis and potentially developing more generic treat-
ments for hyperkeratotic skin conditions.
MATERIALS AND METHODS
Generation of Krt9 / mice
All experiments involving mice followed the UK animal welfare act
guidelines. K9-null mice were generated using Krt9-null C57
Bl/6NTac ES cells as described in the Supplementary Information
online. F1 offspring were identified using Knock-Out Mouse Project
repository genotyping protocols and all experiments were performed
using age-matched littermates.
Histopathology and immunohistochemistry
The fore- and hind-paw footpad epidermis from 8-week-old gender-
matched Krt9þ /þ , Krt9þ / , and Krt9 / littermates (n¼ 3 per
genotype) were dissected and fixed in neutral buffered formalin
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(361387P, VWR International, Leicestershire, UK) for 48 h. Tissues
were dehydrated, paraffin embedded, 7mm sections cut, mounted on
superfrost-plus slides (6310108, VWR International), and dried. For
histopathological analyses, sections were deparaffinized and hema-
toxylin/eosin stained according to standard protocols. Epidermal
thickness was measured using AxioVision Rel. 4.6 software (Zeiss,
Cambridge, UK).
Immunohistochemical staining was performed as previously
described (Leachman et al., 2005) using the primary antibodies and
the dilutions described in Supplementary Table S1 online. Antibody
staining was visualized using anti-mouse or anti-rabbit EnVisionþ
system horseradish peroxidase-conjugated secondary antibodies and
the liquid DABþ substrate chromogen system (Dako, Cambridge-
shire, UK). Fontana–Masson staining was carried as described in
Manual of Histological Demonstration Techniques (Cook, 1974).
All sections were counter-stained with hematoxylin. Images were
acquired using an Axioskop microscope (12067, Zeiss), Axiocam 2
(24700, Zeiss), and AxioVision Rel. 4.6 software.
Immunoblotting
Footpad and inter-footpad epidermis of fore- and hind-paws were
dissected from 8-week-old gender-matched Krt9þ /þ , Krt9þ / , and
Krt9 / littermates (n¼ 3 per genotype) and snap-frozen in liquid
nitrogen. Whole-tissue protein lysates were prepared via mortar and
pestle grinding and reconstituted in 1 denaturing NuPAGE LDS
sample buffer (Life Technologies, Paisley, UK). Immunoblots were
simultaneously probed with 1:2,000 rabbit anti-b-actin (loading
control; ab8227, Abcam, Cambridge, UK) and the primary antibo-
dies/dilutions listed in Supplementary Table S1 online. Blots were
processed and visualized as previously described (Leslie Pedrioli
et al., 2012). Colored images were generated using Adobe Photoshop
(Adobe Systems, San Jose, CA). Semiquantitative immunoblot
analyses were performed using the GelEval 3.5 software (www.
frogdance.dundee.ac.uk) as previously described (Leslie Pedrioli
et al., 2012).
Scanning electron and transmission electron microscopy
For scanning electron microscopy, whole fore- and hind-paws from
8-week-old gender-matched littermates were fixed in Peter’s fixative
(0.08 M sodium cacodylate [pH 7.4], 1% paraformaldehyde, and
1.25% glutaraldehyde) for 24 h. Secondary fixing was performed in
either 1% OsO4 for 1 h or 0.2% OsO4 (aq) for 16–18 h. Specimens
were rinsed in distilled water for 15 min, dehydrated through an
ethanol gradient, and critical-point dried using a BAL-TEC CPD 030
(BAL-TEC, Schalksmu¨hle, Germany). Samples were mounted on
aluminum stubs, coated with 40 nm Au/Pd, and examined using
a Philips XL30 ESEM (Philips, Eindhoven, The Netherlands) and XL
Docu imaging software (Olympus Soft Imaging Solutions Munster,
Germany).
For transmission electron microscopy, skin biopsy specimens were
cut into small pieces (of o1 mm3) and fixed in half-strength
Karnovsky fixative for 4 h at room temperature. After washing in
0.1 M sodium phosphate buffer (pH 7.4), samples were immersed in
1.3% aqueous osmium tetroxide (TAAB Laboratories, Berkshire, UK)
for 2 h. Samples were then incubated in 2% uranyl acetate (Bio-Rad,
Hercules, CA) and dehydrated in a graded ethanol series. Samples
were embedded in epoxy resin via propylene oxide (TAAB Labora-
tories). Ultra-thin sections were stained with uranyl acetate and lead
citrate and examined on a Philips CM10 transmission electron
microscope (Philips).
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